Evidence map›Paper›PMID 41392037›Full record

ArticleScientific reports2025

Mechanistic insights into dissolution enhancement of co-spray dried meloxicam with chitosan and solubilization agent.

Tereza Vařilová, Petra Svačinová, Karl G Wagner, Tomáš Pekárek, Petra Pullmannová, Jan Patera, Kristina Steffens, Oliver Macho, Barbora Vraníková, Zdenka Šklubalová

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tereza VařilováDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203/8, Hradec Králové, 500 05, Czech Republic.
Petra SvačinováDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203/8, Hradec Králové, 500 05, Czech Republic. svacp3aa@faf.cuni.cz.
Karl G WagnerDepartment of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, Gerhard-Domagk-Str. 3, 53121, Bonn, Germany.
Tomáš PekárekZentiva, k.s., U Kabelovny 130, 102 37, Prague 10, Czech Republic.
Petra PullmannováSkin Barrier Research Group, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203/8, Hradec Králové, 500 05, Czech Republic.
Jan PateraDepartment of Organic Technology, University of Chemistry and Technology Prague, Technická 5, Prague, 166 28, Czech Republic.
Kristina SteffensDepartment of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, Gerhard-Domagk-Str. 3, 53121, Bonn, Germany.
Oliver MachoInstitute of Process Engineering, Faculty of Mechanical Engineering STU, Bratislava, Námestie slobody 17, 812 31, Bratislava 1, Slovak Republic.
Barbora VraníkováDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203/8, Hradec Králové, 500 05, Czech Republic.
Zdenka ŠklubalováDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203/8, Hradec Králové, 500 05, Czech Republic.

Funding

Ministry of Education, Youth and Sports (MEYS), Czech Republic CZ.02.01.01/00/22_008/0004607
6 · The paper itself

Abstract

This study presents a co-spray drying formulation approach to enhance the dissolution rate of meloxicam (MX), a poorly soluble model drug, by combining it with chitosan (CHIT) and sodium lauryl sulfate (SLS). Ternary formulations were prepared using both mini- and medium-scale spray dryers and compared with physical mixtures and RAW MX. In vitro dissolution testing revealed a significant increase in the release rate, with up to 80% of MX dissolved within 5 min. A comprehensive set of solid-state analytical techniques (XRPD, FTIR, and confocal Raman microscopy) revealed subtle changes in MX crystallinity and hydrogen-bonding interactions with both excipients. These findings support three key mechanisms contributing to enhanced dissolution: (i) reduced agglomeration of MX via adsorption onto the CHIT surface, (ii) improved wettability of products due to the presence of SLS, and (iii) increased matrix hydrophilicity facilitating drug-medium contact. The successful scale-up using a medium-scale spray dryer demonstrated the feasibility of this strategy for industrial application. The results highlight co-spray drying with functional excipients as a robust and scalable method for improving the biopharmaceutical performance of poorly soluble drugs. The simple co-spraying of the CHIT dispersion with the drug solution, without the need to dissolve the chitosan, is additional advantage.

Indexed as

ChitosanMeloxicamDrug CompoundingDrug LiberationExcipientsHydrogen BondingSodium Dodecyl SulfateSolubilitySpectroscopy, Fourier Transform InfraredSpray DryingChitosanExcipientsMeloxicamSodium Dodecyl SulfateChitosanCo-spray dryingDissolution enhancementMeloxicamSodium lauryl sulphate

Identifiers

PMID41392037
PMCPMC12800161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.